True North Advisors’s ResMed RMD Stock Holding History

True North Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1M	Sell	5,141 -281	-5%	-$58.2K	0.1%	115
2026 Q1	$1.22M	Sell	5,422 -59	-1%	-$14.7K	0.14%	97
2025 Q4	$1.32M	Buy	5,481 +285	+5%	+$72.9K	0.17%	91
2025 Q3	$1.42M	Buy	5,196 +349	+7%	+$95.3K	0.23%	70
2025 Q2	$1.25M	Buy	4,847 +3,642	+302%	+$869K	0.24%	79
2025 Q1	$270K	Buy	1,205 +80	+7%	+$18.7K	0.05%	206
2024 Q4	$257K	Buy	+1,125	New	+$271K	0.06%	161
2022 Q1	–	Sell	-32,100	Closed	-$8.36M	–	230
2021 Q4	$8.36M	Hold	32,100	–	–	1.41%	12
2021 Q3	$8.46M	Hold	32,100	–	–	1.67%	11
2021 Q2	$7.91M	Hold	32,100	–	–	1.65%	11
2021 Q1	$6.23M	Hold	32,100	–	–	1.48%	13
2020 Q4	$6.82M	Hold	32,100	–	–	1.75%	11
2020 Q3	$5.5M	Sell	32,100 -60,000	-65%	-$11.1M	1.61%	12
2020 Q2	$17.7M	Hold	92,100	–	–	4.25%	4
2020 Q1	$13.6M	Hold	92,100	–	–	4.63%	5
2019 Q4	$14.3M	Buy	+92,100	New	+$13.3M	4.02%	8

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

True North Advisors's RMD Position: Q2 2026 in Review

True North Advisors reduced its ResMed (RMD) stake by 5.2% in Q2 2026, selling an estimated $58.2K and leaving 5,141 shares worth $1M. The position accounts for 0.1% of the portfolio, ranked #115.

True North Advisors first reported a position in RMD in Q4 2019 and has held it in 16 quarters since. The position peaked at $17.7M in Q2 2020. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

True North Advisors held 5,141 shares of ResMed worth $1M as of Q2 2026.
True North Advisors sold 281 ResMed shares in Q2 2026, an estimated $58.2K.
ResMed made up 0.1% of True North Advisors's portfolio in Q2 2026, its #115 holding.
True North Advisors first reported a position in ResMed in Q4 2019 and has held it in 16 quarters since.
True North Advisors's ResMed position peaked at $17.7M in Q2 2020.
882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on True North Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.